Previous in vivo and in vitro studies have linked higher levels of IGF-1R and its ligands with various types of cancer development and progression including breast cancer [7–10], prostate cancer [11], myeloma [12] and colon cancer [13, 14]. This evidence concerns the gene IGF1R and breast carcinoma.